• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化组织病理学病变的临床及生化表现。熊去氧胆酸 - 原发性胆汁性肝硬化组。

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.

作者信息

Poupon R, Chazouillères O, Balkau B, Poupon R E

机构信息

Service d'Hépato-Gastroentérologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, France.

出版信息

J Hepatol. 1999 Mar;30(3):408-12. doi: 10.1016/s0168-8278(99)80098-1.

DOI:10.1016/s0168-8278(99)80098-1
PMID:10190722
Abstract

BACKGROUND/AIMS: This study aimed to assess the relationships which may link elementary histological lesions with symptoms and biochemistries in primary biliary cirrhosis.

METHODS

We studied 103 patients with primary biliary cirrhosis who participated in a double-blind, placebo-controlled trial of UDCA treatment and in whom liver biopsy specimens obtained at entry were reassessed. Relationships between histological features, fatigue, pruritus and biochemistries were calculated by using exact tests for 2 ordinal variables.

RESULTS

The degrees of severity of fatigue and pruritus were significantly and exclusively related to the presence of florid interlobular bile duct lesions (p<0.01 and p<0.02, respectively). The only laboratory parameter associated with the presence of interlobular bile duct florid lesion was IgM level. The most discriminant biochemical test for interlobular bile duct paucity was gamma glutamyltranspeptidase activity. The degree of severity of both lymphocytic hepatocellular piecemeal necrosis and lobular inflammation and necrosis was mainly associated with increased gammaglobulin and IgG levels and to a lesser extent with increased IgM and aspartate aminotransferase levels. The extent of fibrosis was mainly associated with gammaglobulin levels and to a lesser degree with serum albumin, bilirubin and IgG levels.

CONCLUSIONS

Symptoms and biochemistries classically used to assess primary biliary cirrhosis reflect in part the degree of severity of the main elementary histological lesions. We propose that the picture of primary biliary cirrhosis results from the clinical and biochemical expression of three distinct processes, e.g., bile duct inflammation and destruction, parenchymal inflammation and necrosis, and fibrosis. The various combinations of these processes may explain why the spectrum of primary biliary cirrhosis varies from typical primary biliary cirrhosis to mixed type of primary biliary cirrhosis and autoimmune hepatitis and suggests that the response to therapies may depend on the predominance of each process in a given patient.

摘要

背景/目的:本研究旨在评估原发性胆汁性肝硬化中可能将基本组织学病变与症状及生化指标联系起来的关系。

方法

我们研究了103例原发性胆汁性肝硬化患者,这些患者参与了熊去氧胆酸治疗的双盲、安慰剂对照试验,并对入组时获取的肝活检标本进行了重新评估。通过对两个有序变量进行精确检验来计算组织学特征、疲劳、瘙痒与生化指标之间的关系。

结果

疲劳和瘙痒的严重程度与小叶间胆管显著病变的存在显著且唯一相关(分别为p<0.01和p<0.02)。与小叶间胆管显著病变存在相关的唯一实验室参数是IgM水平。对小叶间胆管缺乏最具鉴别力的生化检测是γ-谷氨酰转肽酶活性。淋巴细胞性肝细胞桥接坏死以及小叶炎症和坏死的严重程度主要与γ球蛋白和IgG水平升高相关,在较小程度上与IgM和天冬氨酸转氨酶水平升高相关。纤维化程度主要与γ球蛋白水平相关,在较小程度上与血清白蛋白、胆红素和IgG水平相关。

结论

传统上用于评估原发性胆汁性肝硬化的症状和生化指标部分反映了主要基本组织学病变的严重程度。我们提出原发性胆汁性肝硬化的情况是由三个不同过程的临床和生化表现引起的,即胆管炎症和破坏、实质炎症和坏死以及纤维化。这些过程的不同组合可以解释为什么原发性胆汁性肝硬化的范围从典型的原发性胆汁性肝硬化到原发性胆汁性肝硬化与自身免疫性肝炎的混合型,并且表明对治疗的反应可能取决于特定患者中每个过程的主导程度。

相似文献

1
Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.原发性胆汁性肝硬化组织病理学病变的临床及生化表现。熊去氧胆酸 - 原发性胆汁性肝硬化组。
J Hepatol. 1999 Mar;30(3):408-12. doi: 10.1016/s0168-8278(99)80098-1.
2
Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.原发性胆汁性肝硬化的组织病理学研究及熊去氧胆酸治疗对组织学进展的影响。
Hepatology. 1999 Apr;29(4):1007-12. doi: 10.1002/hep.510290444.
3
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.熊去氧胆酸治疗的原发性胆汁性肝硬化患者肝纤维化和淋巴细胞性碎屑样坏死的生化标志物
Liver Int. 2004 Jun;24(3):187-93. doi: 10.1111/j.1478-3231.2004.0918.x.
4
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征:临床特征及对治疗的反应
Hepatology. 1998 Aug;28(2):296-301. doi: 10.1002/hep.510280203.
5
[Clinical and pathological characteristics of primary biliary cirrhosis].[原发性胆汁性肝硬化的临床与病理特征]
Zhonghua Gan Zang Bing Za Zhi. 2002 Oct;10(5):334-7.
6
Autoimmune overlapping syndromes.自身免疫性重叠综合征
Clin Liver Dis. 2003 Nov;7(4):865-78. doi: 10.1016/s1089-3261(03)00092-8.
7
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.熊去氧胆酸治疗原发性胆汁性肝硬化的多中心对照试验。熊去氧胆酸-原发性胆汁性肝硬化研究组。
N Engl J Med. 1991 May 30;324(22):1548-54. doi: 10.1056/NEJM199105303242204.
8
Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.原发性胆汁性肝硬化患者长期服用熊去氧胆酸后胆汁酶水平及瘙痒症状的改善
Am J Gastroenterol. 1990 Jan;85(1):15-23.
9
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.熊去氧胆酸治疗原发性胆汁性肝硬化。一项双盲多中心随机试验的中期分析。熊去氧胆酸 - 原发性胆汁性肝硬化研究组
J Hepatol. 1990 Jul;11(1):16-21. doi: 10.1016/0168-8278(90)90265-s.
10
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis.熊去氧胆酸对原发性胆汁性肝硬化典型胆管病变的影响。
Hepatology. 1999 Sep;30(3):602-5. doi: 10.1002/hep.510300315.

引用本文的文献

1
Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead.自身免疫性肝病的临床管理:当前的节点、机遇与挑战
Immunol Res. 2025 Apr 7;73(1):67. doi: 10.1007/s12026-025-09622-9.
2
Comparing animal well-being between bile duct ligation models.比较胆管结扎模型中的动物福利。
PLoS One. 2024 Jul 1;19(7):e0303786. doi: 10.1371/journal.pone.0303786. eCollection 2024.
3
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).原发性胆汁性胆管炎的诊断与管理指南(2021年)
J Clin Transl Hepatol. 2023 Jun 28;11(3):736-746. doi: 10.14218/JCTH.2022.00347. Epub 2023 Feb 10.
4
Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis.单细胞测序:揭示肿瘤转移机制的有前途的方法。
J Hematol Oncol. 2022 May 12;15(1):59. doi: 10.1186/s13045-022-01280-w.
5
Changed Profile of Serum Transferrin Isoforms in Primary Biliary Cholangitis.原发性胆汁性胆管炎患者血清转铁蛋白异构体谱的变化
J Clin Med. 2020 Sep 8;9(9):2894. doi: 10.3390/jcm9092894.
6
Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches.原发性胆汁性胆管炎的临床进展:趋势、流行病学、诊断及新治疗方法
J Clin Transl Hepatol. 2020 Mar 28;8(1):49-60. doi: 10.14218/JCTH.2019.00049. Epub 2020 Jan 29.
7
Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.胆汁淤积性肝病的预防性护理:给专科医生和亚专科医生的经验之谈
Liver Res. 2019 Jun;3(2):118-127. doi: 10.1016/j.livres.2019.04.001. Epub 2019 May 27.
8
A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.胃肠病学家对原发性胆汁性胆管炎的实用综述
Gastroenterol Hepatol (N Y). 2019 Mar;15(3):145-154.
9
Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.熊去氧胆酸通过线粒体途径诱导人黑色素瘤细胞凋亡。
Oncol Rep. 2019 Jan;41(1):213-223. doi: 10.3892/or.2018.6828. Epub 2018 Oct 29.
10
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.英国胃肠病学会/英国原发性胆汁性胆管炎治疗和管理指南。
Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.